Giovanni Scambia Selected Research

Carcinoma (Carcinomatosis)

2/2024	Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
1/2024	TRImodal DEfinitive invasive vagiNal carcinoma Treatment (TRIDENT protocol): how a standardized approach may change prognostic outcomes.
12/2023	Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
8/2023	Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study.
8/2023	Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
1/2023	Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
12/2022	Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma.
11/2022	MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis.
7/2022	Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE).
1/2022	Clear cell carcinoma of the endometrium.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Scambia Research Topics

Disease

289	Neoplasms (Cancer) 04/2024 - 02/2002
256	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 01/2002
118	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2024 - 03/2002
101	Endometrial Neoplasms (Endometrial Cancer) 04/2024 - 08/2002
59	Carcinoma (Carcinomatosis) 02/2024 - 03/2002
52	Ovarian Epithelial Carcinoma 04/2024 - 07/2003
39	Neoplasm Metastasis (Metastasis) 03/2024 - 07/2004
29	Breast Neoplasms (Breast Cancer) 03/2024 - 07/2006
24	Endometriosis 05/2024 - 02/2004
20	Infections 01/2023 - 02/2005
19	Vulvar Neoplasms (Vulvar Cancer) 01/2023 - 11/2003
17	Adenocarcinoma 03/2024 - 07/2003
17	Disease Progression 12/2023 - 02/2014
14	Residual Neoplasm 03/2024 - 01/2003
13	Neutropenia 12/2021 - 07/2004
12	Postoperative Pain 07/2023 - 05/2003
10	Pelvic Organ Prolapse 12/2023 - 01/2017
9	Triple Negative Breast Neoplasms 02/2024 - 04/2020
9	Lymphatic Metastasis 11/2023 - 11/2003
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2007
9	COVID-19 01/2022 - 11/2020
8	Obesity 02/2024 - 05/2014
8	Intraoperative Complications 12/2023 - 09/2015
7	Pathologic Complete Response 01/2023 - 06/2008
7	Hypertension (High Blood Pressure) 10/2021 - 10/2014
7	Hypoxia (Hypoxemia) 12/2020 - 02/2008
7	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 08/2008
6	Inflammation (Inflammations) 03/2024 - 01/2018
6	Fallopian Tube Neoplasms 02/2024 - 02/2014
6	Peritoneal Neoplasms 12/2023 - 12/2018
6	Margins of Excision 10/2023 - 01/2018
6	Nausea 04/2023 - 08/2014
6	Wounds and Injuries (Trauma) 01/2023 - 08/2016
6	Leiomyosarcoma 01/2023 - 01/2017
6	Leiomyoma (Uterine Fibroids) 01/2022 - 04/2012
6	Carcinogenesis 12/2021 - 04/2004

Drug/Important Bio-Agent (IBA)

108	PlatinumIBA 03/2024 - 01/2003
60	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 03/2002
35	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 10/2003
34	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2009
34	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2002
28	Bevacizumab (Avastin)FDA Link 03/2024 - 12/2013
22	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 10/2017
21	liposomal doxorubicin (Doxil)FDA Link 02/2024 - 01/2002
20	Indocyanine Green (Cardio-Green)FDA LinkGeneric 02/2024 - 09/2017
19	olaparibIBA 01/2023 - 04/2018
17	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 02/2002
15	Estrogens (Estrogen)FDA Link 11/2023 - 11/2003
14	TubulinIBA 04/2018 - 01/2005
13	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2003
13	1-dodecylpyridoxal (PLD)IBA 12/2023 - 08/2005
12	Hormones (Hormone)IBA 03/2024 - 02/2006
12	Immune Checkpoint InhibitorsIBA 02/2024 - 04/2020
11	TrabectedinIBA 02/2024 - 09/2013
11	Gemcitabine FDA Link 02/2024 - 01/2002
11	taxaneIBA 01/2022 - 03/2003
11	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2011 - 08/2002
10	Estrogen ReceptorsIBA 09/2019 - 06/2007
9	pembrolizumabIBA 03/2024 - 01/2021
9	Monoclonal AntibodiesIBA 12/2023 - 03/2010
9	AntigensIBA 12/2023 - 01/2008
9	rucaparibIBA 01/2023 - 10/2017
7	Nucleic AcidsIBA 03/2024 - 01/2018
7	Topotecan (Hycamtin)FDA LinkGeneric 02/2024 - 07/2004
7	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 10/2020
7	SuspensionsIBA 02/2023 - 09/2018
7	AntibodiesIBA 01/2023 - 09/2013
7	Messenger RNA (mRNA)IBA 01/2018 - 07/2006
6	Taxoids (Taxanes)IBA 12/2023 - 03/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 12/2004
6	MicroRNAs (MicroRNA)IBA 08/2021 - 12/2008

Therapy/Procedure

158	Drug Therapy (Chemotherapy) 03/2024 - 06/2002
126	Therapeutics 04/2024 - 03/2003
76	Hysterectomy 04/2024 - 06/2006
66	Lymph Node Excision (Lymph Node Dissection) 03/2024 - 04/2005
64	Neoadjuvant Therapy 03/2024 - 03/2002
52	Radiotherapy 04/2024 - 10/2004
44	Cytoreduction Surgical Procedures 12/2023 - 10/2003
27	Laparotomy 03/2024 - 08/2002
24	Minimally Invasive Surgical Procedures 11/2023 - 05/2009
22	Immunotherapy 03/2024 - 10/2002
21	Hyperthermic Intraperitoneal Chemotherapy 03/2024 - 08/2011
21	Chemoradiotherapy 03/2024 - 01/2004
17	Operative Time 05/2024 - 08/2002
15	Operative Surgical Procedures 12/2023 - 08/2005
14	Precision Medicine 03/2024 - 01/2019
12	Salpingo-oophorectomy 04/2024 - 12/2009
11	Adjuvant Chemotherapy 04/2024 - 01/2003
11	Pelvic Exenteration 09/2023 - 09/2010
10	Length of Stay 05/2024 - 01/2016
9	Conservative Treatment 03/2024 - 07/2005
9	Trachelectomy 02/2024 - 03/2011
9	Cesarean Section (Caesarean Section) 01/2023 - 01/2012
7	Anesthesia 07/2023 - 07/2016
7	Salvage Therapy 06/2021 - 08/2005
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2024 - 04/2010
6	Robotic Surgical Procedures 02/2024 - 07/2018
6	Ovariectomy (Oophorectomy) 03/2023 - 06/2014
6	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2020 - 04/2011
6	Uterine Myomectomy 08/2018 - 11/2005